Vivek Ambade

Dr. Vivek Ambade


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2020 in Journal of Medical Virology
Verified
Journal Article
Open access
PDF file
VAVivek Ambade
Vivek Ambade
Recently, Huang J et al 1 have published an article in this journal, wherein they concluded that hypoalbuminemia is associated with the outcome of COVID‐19.

1 January 2022 in Journal of Medical Biochemistry
Verified
Journal Article
Open access
PDF file
VAVivek Ambade
Vivek Ambade
SASonia Ambade
Sonia Ambade
Researchers around the world have experienced the dual nature of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), 'tragically lethal in some people while surprisingly benign in others'. There have been congregating studies of the novel coronavirus disease (COVID-19), a disease that mainly attacks the lungs but also has mystifying effects on the heart, kidneys and brain. Researchers are also gathering information to ascertain why people are dying of COVID-19, whether it is solely a respiratory disorder, a coagulation disorder or multi-organ failure. Alterations in laboratory parameters like lactate, ferritin and albumin have been established as risk factors and are associated with outcomes, yet none have not been sub stantiated with a scientific biochemical rationale. SARSCoV-2 affects the alveolar type II epithelial cells which significantly disturbs its surfactant homeostasis, deprives Na,K-ATPase of ATP, thereby disturbing the alveolar lining fluid which then gradually decreases the alveolar gaseous exchange initiating the intracellular hypoxic conditions. This activates AMP-activated kinase, which further inhibits Na,K-ATPase, which can progressively cause respiratory distress syndrome. The virus may infect endothelial cell (EC) which, being less energetic, cannot withstand the huge energy requirement towards viral replication. There - fore glycolysis, the prime energy generating pathway, must be mandatorily upregulated. This can be achieved by Hypoxia-inducible factor-1 (HIF-1). However, HIF-1 also activates transcription of von Willebrand factor, plasminogen activator inhibitor-1, and suppresses the release of thrombomodulin. This in turn sets off the coagulation cascade that can lead to in-situ pulmonary thrombosis and micro clots. The proposed HIF-1 hypothesis justifies various features, biochemical alteration, laboratory as well as autopsy findings such as respiratory distress syndrome, increased blood ferritin and lactate levels, hypoalbuminemia, endothelial invasion, in-situ pulmonary thrombosis and micro clots, and multi-organ failure in COVID-19.


19 March 2024 in Indian Journal of Clinical Biochemistry
Verified
Journal Article
Closed access
PDF file
VAVivek Ambade
Vivek Ambade
SASonia Ambade
Sonia Ambade
DGDeepak B. Gundpatil
Deepak B. Gundpatil
KBKapil Bhatia
Kapil Bhatia
PSPrasanna Sanas
Prasanna Sanas

8 July 2026 in Journal of Ayurveda and Integrative Medicine
Verified
Journal Article
Open access
VAVivek Ambade
Vivek Ambade
SBShilpika Bagh
Shilpika Bagh
Sibin M KSibin M K
Sibin M K
PSPrasanna Sanas
Prasanna Sanas
VSVaibhav Sharma
Vaibhav Sharma
Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), imposes a significant metabolic and nutritional burden on the human host. Viral replication requires synthesis of structural proteins (S, E, M, and N), which in turn depends on an adequate supply of amino acids. While the human body can synthesize all nucleotides, it cannot synthesize eight essential amino acids (EAAs), which must be derived from dietary intake or through catabolism of endogenous protein stores such as skeletal muscle and albumin. Despite numerous dietary advisories for COVID-19 patients, including those from international agencies, none are grounded in a biochemical analysis of viral amino acid requirements. This study aimed to determine the amino acid distribution of SARS-CoV-2 structural proteins and to identify nutritionally optimal, economically accessible staple and widely consumed foods capable of counteracting the essential amino acid burden during COVID-19. In this computational study, the amino acid profiling of SARS-CoV-2 structural proteins was performed using bioinformatics analysis of genomic sequences obtained from the GenBank database. The amino acid composition of commonly consumed foods was derived from the Indian Food Composition Tables (IFCT) 2017. Viral amino acid requirements were quantitatively compared with the amino acid profiles of cereals, millets, legumes, nuts, milk, and eggs to assess their suitability in meeting essential amino acid demands. Synthesis of SARS-CoV-2 structural proteins required all 20 amino acids. Essential amino acids constituted 42.8% of the total amino acid requirement, with branched-chain amino acids (valine, leucine, and isoleucine) accounting for approximately 23%. The nutritional load per virion ranged from 1.6% for methionine to 11.3% for leucine. Rice, wheat, maize, legumes, and even expensive nuts like almond, cashew nut, pistachio nuts and walnut were insufficient in meeting the most abundantly required EAAs. In contrast, millet-based diets, particularly combinations of pearl millet with sorghum or foxtail millet, showed superior amino acid complementarity. Cow milk closely matched overall EAA requirements, while foxtail millet supplemented with eggs provided an optimal mixed-diet option. This study provides a biochemical rationale for dietary management of COVID-19 and identifies Indian traditional millets as a nutritionally effective and integrative dietary strategy to mitigate essential amino acid burden during SARS-CoV-2 infection.